Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Analytical interferences are very common in clinical laboratories, so professionals must develop strategies for their detection, avoiding incorrect results that can lead to inappropriate diagnoses and treatments.
Methods: An isolated 1040 error (absorbance-related) in the Alanine Aminotransferase2 (ALT2) assay performed on the Abbott Alinity c that occurred in 158 samples over 7 months was investigated. Highly lipemic or hemolyzed samples were excluded, and an error due to an increased concentration of total proteins was ruled out, all of which are documented analytical interferences.
Results: We isolated immunoglobulin (Ig) with an increased concentration (monoclonal components: 149 IgM, 7 IgG, and 2 IgA) from all analyzed samples, so the presence of this error solely in the alanine aminotransferase (ALT) assay had a 100% positive predictive value for monoclonal gammopathy. Serum viscosity was elevated in all cases, which is the reason for the detected interference. Treatment of IgM samples with dithiothreitol confirmed that dissociation of the pentamers eliminates the error in ALT determination.
Conclusions: The detection of this interference in samples from patients without recent immunoglobulin determinations indicates the presence of a significant and isolated increase in the concentration of one of them, potentially leading to the diagnosis of a previously unknown monoclonal gammopathy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/jalm/jfaf115 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Rare Case of Plasmablastic Myeloma After Renal Transplant.
Exp Clin Transplant
August 2025
>From the University Clinic for Nephrology, Faculty of Medicine, Saints Cyril and Methodius University in Skopje, Skopje, North Macedonia.
Posttransplant lymphoproliferative disorders are a serious complication after solid-organ transplant, with a reported incidence from 2% to 20%. Plasma cell neoplasms in solid-organ transplants represent a rare but increasingly serious complication after solid-organ transplant. We report a case of plasmablastic myeloma, a very rare variant of multiple myeloma with aggressive course and poor prognosis.
View Article and Find Full Text PDFFree Light Chain Multiple Myeloma: Atypical Appearance on Serum Immunofixation.
Clin Lab
September 2025
Background: Light chain multiple myeloma (LCMM) is a malignant hematological disease characterized by bone marrow infiltration by tumor plasma cells and the secretion of monoclonal free light chains (κ or λ). It is often di-agnosed through hypogammaglobulinemia detected by serum protein electrophoresis, followed by immunotyping showing a monoclonal band in free light chains. However, the structure of monoclonal light chains can sometimes complicate laboratory findings.
View Article and Find Full Text PDFExploring research advances and future trends in drug resistance in multiple myeloma: A comprehensive bibliometric analysis.
Medicine (Baltimore)
September 2025
Nanchang Bright Eye Hospital, Nanchang, Jiangxi, China.
Introduction: This bibliometric analysis aims to explore global trends, research hotspots, and future directions in multidrug resistance of multiple myeloma (MM), providing insights for overcoming resistance mechanisms and optimizing therapeutic strategies.
Methods: We analyzed 3300 publications indexed in the Web of Science Core Collection (2015-2024) using CiteSpace and VOSviewer. Multidimensional evaluations of countries/regions, institutions, authors, journals, and keywords were conducted, supplemented by visual network mapping to elucidate research dynamics and collaborative patterns.
Exploring multiple myeloma pathobiology and immune cell signatures: Evidence from bidirectional genetic analysis.
Medicine (Baltimore)
September 2025
Department of Geriatrics, Beijing Haidian Hospital, Beijing, China.
The causal relationship between immune cell signatures and multiple myeloma (MM) pathobiology remains incompletely understood. This study aimed to explore the bidirectional causal associations between 731 circulating immune cell traits and MM risk using a two-sample, bidirectional Mendelian randomization (MR) approach. Two-sample MR analyses were conducted utilizing genome-wide association study (GWAS) summary statistics for 731 immune cell phenotypes and MM GWAS datasets.
View Article and Find Full Text PDFClinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy-Associated Myopathies.
Neurology
October 2025
Department of Neurology, Mayo Clinic, Rochester, MN.
Monoclonal gammopathy-associated myopathies (MGAMs) are rare yet treatable myopathies that occur in association with monoclonal gammopathies. These myopathies include light chain (AL) amyloidosis myopathy, sporadic late-onset nemaline myopathy (SLONM), scleromyxedema with associated myopathy, and newly reported monoclonal gammopathy-associated glycogen storage myopathy (MGGSM), including the vacuolar myopathy with monoclonal gammopathy and stiffness. All these 4 distinct subtypes of MGAMs typically present in patients aged 40 or older, frequently with a subacute onset of rapidly progressive proximal and axial muscle weakness.
View Article and Find Full Text PDF